Studying the Impact of a Medication Use Evaluation by the Community Pharmacist

Joke Wuyts453 enrolled

Overview

In this intervention study, 75 Belgian community pharmacies each recruit 12 patients for an intermediate medication review. For each patient, the identified drug-related problems and subsequent interventions are registered using the PharmDisc classification. In a subset of Dutch speaking patients, a pretest-posttest single group design is used to measure the impact of this review on patient related outcomes using questionnaires. The primary outcome is the medication related quality of life, measured via the living with medicines questionnaire. Other patient reported outcomes include adherence, self-management, patient satisfaction, fall incidents and use of emergency healthcare services. Medication records are also collected to objectively measure adherence before and after the intervention.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

453

Conditions

Aging

Interventions

The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.

Additional data collection: questionnairesBEHAVIORAL

Pre-post study design. At three timepoints, data is collected: * before the medication review (T-1week) * during the review (Tweek 3) * after the review (Tweek12) The questionnaire provide data for the outcomes: medication related quality of life, adherence questionnaire, service satisfaction, use of emergency health services, self-management

Eligibility

Sex: ALLMin age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients should be 70 years or older * Use five or more drugs on a regular basis (prescription or non-prescription drugs) * Live in the ambulatory setting * Obtain his medication from this pharmacy on a regular basis Exclusion Criteria: \-

Outcomes

Primary Outcomes

Drug-related problems & interventions

Using the validated PharmDisc classification tool

Time frame: One timeframe: during the medication review

Change in medication related quality of life

using the Living with medicines questionnaire

Time frame: Three timepoints: Before the review, during review (week 3), after the review (week 12)

Secondary Outcomes

Change in adherence

using dispensing data

Time frame: 9 months before and after the intervention

Change in adherence

using the PROMAS questionnaire

Time frame: Two timepoints: Before the review, after the review (week 12)

Change in self-management

using the PAM questionnaire

Time frame: Two timepoints: Before the review, after the review (week 12)

Change in use of emergency healthcare services & fall incidents

using own questions

Time frame: Two timepoints: Before the review, after the review (week 12)

Satisfaction with the new service

Using the PSPSQ2 questionnaire

Time frame: One timepoint: during the review (week 3)